• Exchange: Xetra
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

Roche Holding AG

+ Add to Watchlist

RHO5:GR

230.850 EUR 1.689 0.73%

As of 03:23:57 ET on 10/24/2014.

Snapshot for Roche Holding AG (RHO5)

Open: 230.950 Day's Range: 229.657 - 232.175 Volume: 253
Previous Close: 232.539 52wk Range: 189.250 - 236.350 1-Yr Rtn: +18.28%

Stock Chart for RHO5

No chart data available.
  • RHO5:GR 230.850
  • 1D
  • 1M
  • 1Y
232.539
Interactive RHO5 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for RHO5

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 18.9670
Relative P/E vs. DAX -
Earnings Per Share (CHF) (ttm) -
Est. EPS (CHF) (12/2014) 14.7930
Est. PEG Ratio 3.2356
Market Cap (M EUR) 198,474.02
Shares Outstanding (M) 702.56
30 Day Average Volume 7,372
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 2.76%
Cash Dividend (CHF) 7.8000
Dividend Ex-Date 03/06/2014
5 Year Dividend Growth 14.53%
Next Earnings Announcement 01/28/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for RHO5

  • Revenue
  • Net Income (M/CHF)
  • Profit Margin (%)

Company Profile & Key Executives for RHO5

Roche Holding AG develops and manufactures pharmaceutical and diagnostic products. The Company produces prescription drugs in the areas of cardiovascular, infectious, autoimmune, and respiratory diseases, dermatology, metabolic disorders, oncology, transplantation, and the central nervous system.

Severin SchwanChief Executive OfficerAlan HippeChief Financial & IT Officer
Roland DiggelmannCOO:DiagnosticsGottlieb A KellerGeneral Counsel
More Company Profile & Key Executives for RHO5

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil